DK0402752T3 - N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents

N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Info

Publication number
DK0402752T3
DK0402752T3 DK90110676.5T DK90110676T DK0402752T3 DK 0402752 T3 DK0402752 T3 DK 0402752T3 DK 90110676 T DK90110676 T DK 90110676T DK 0402752 T3 DK0402752 T3 DK 0402752T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
aryl
hydrogen
heteroberl
purine
Prior art date
Application number
DK90110676.5T
Other languages
Danish (da)
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Larry Davis
Gordon Edward Olson
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of DK0402752T3 publication Critical patent/DK0402752T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Television Signal Processing For Recording (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK90110676.5T 1989-06-09 1990-06-06 N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler DK0402752T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/363,837 US5017578A (en) 1989-06-09 1989-06-09 N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents

Publications (1)

Publication Number Publication Date
DK0402752T3 true DK0402752T3 (da) 1996-01-15

Family

ID=23431950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90110676.5T DK0402752T3 (da) 1989-06-09 1990-06-06 N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Country Status (21)

Country Link
US (1) US5017578A (fr)
EP (1) EP0402752B1 (fr)
JP (1) JPH06102663B2 (fr)
KR (2) KR100199524B1 (fr)
CN (1) CN1029968C (fr)
AT (1) ATE127807T1 (fr)
AU (1) AU636351B2 (fr)
CA (1) CA2018563C (fr)
DE (1) DE69022294T2 (fr)
DK (1) DK0402752T3 (fr)
ES (1) ES2078267T3 (fr)
FI (1) FI902850A0 (fr)
GR (1) GR3017743T3 (fr)
HU (1) HU207320B (fr)
IE (1) IE68433B1 (fr)
IL (1) IL94665A (fr)
MX (1) MX21088A (fr)
NO (1) NO902555L (fr)
NZ (1) NZ233970A (fr)
PT (1) PT94297B (fr)
ZA (1) ZA904443B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 Ｎ−（置換アミノ）ピロール誘導体、その製造方法及び除草剤
SK146096A3 (en) * 1994-05-10 1997-07-09 Sandoz Ltd Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
CA2450073C (fr) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
CN100447143C (zh) * 2003-08-15 2008-12-31 Irm责任有限公司 作为rtk抑制剂的6-取代的苯胺基嘌呤
SG145748A1 (en) * 2003-08-15 2008-09-29 Irm Llc 6-substituted anilino purines as rtk inhibitors
EP3827747A1 (fr) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Système pharma-informatique
EP2063905B1 (fr) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104744470A (zh) * 2014-10-31 2015-07-01 合肥平光制药有限公司 一种茶碱的合成方法
WO2017160922A1 (fr) 2016-03-16 2017-09-21 Kalyra Pharmaceuticals, Inc. Composés analgésiques
CN106632339B (zh) * 2016-12-16 2018-11-27 温州医科大学 一种6-取代-9h-嘌呤类衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016378A (en) * 1959-07-01 1962-01-09 Thomae Gmbh Dr K Amino-substituted purine derivatives
US3796700A (en) * 1970-06-30 1974-03-12 Takedo Chem Ind Ltd Adenosine derivatives and the production thereof
JPS4935635B1 (fr) * 1970-12-28 1974-09-25
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US3936454A (en) * 1973-08-14 1976-02-03 Warner-Lambert Company 5-Amino-4-chloro-6-(substituted amino)-pyrimidines
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
DE3576344D1 (de) * 1984-04-18 1990-04-12 Whitby Research Inc Cardio-vasodilatatore n-6-substituierte adenosine.
US4657897A (en) * 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
CA1254888A (fr) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicyclo-adenosines
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US4780452A (en) * 1986-09-08 1988-10-25 Burroughs Wellcome Co. F-substituted-3-β-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
NO902555D0 (no) 1990-06-08
KR100210179B1 (ko) 1999-07-15
IE902077L (en) 1990-12-09
KR100199524B1 (ko) 1999-06-15
EP0402752B1 (fr) 1995-09-13
EP0402752A1 (fr) 1990-12-19
IL94665A (en) 1994-06-24
KR910000730A (ko) 1991-01-30
US5017578A (en) 1991-05-21
FI902850A0 (fi) 1990-06-07
CN1029968C (zh) 1995-10-11
GR3017743T3 (en) 1996-01-31
PT94297B (pt) 1997-01-31
ZA904443B (en) 1991-03-27
ES2078267T3 (es) 1995-12-16
NZ233970A (en) 1993-02-25
HU903768D0 (en) 1990-11-28
HU207320B (en) 1993-03-29
IL94665A0 (en) 1991-04-15
AU5691990A (en) 1990-12-13
CA2018563C (fr) 2000-09-19
DE69022294D1 (de) 1995-10-19
ATE127807T1 (de) 1995-09-15
CN1047866A (zh) 1990-12-19
PT94297A (pt) 1991-02-08
JPH0324080A (ja) 1991-02-01
MX21088A (es) 1993-11-01
CA2018563A1 (fr) 1990-12-09
HUT54156A (en) 1991-01-28
AU636351B2 (en) 1993-04-29
JPH06102663B2 (ja) 1994-12-14
IE68433B1 (en) 1996-06-12
DE69022294T2 (de) 1996-03-14
NO902555L (no) 1990-12-10

Similar Documents

Publication Publication Date Title
GR3026318T3 (en) N-substituted-4-pyrimidinamines and -pyrimidindiamines, a process for their preparation and their use as medicaments
DK0402752T3 (da) N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0430201T3 (fr)
NO901385D0 (no) Karbonatderivater av eserolin, fremgangsmaate for fremstilling derav og deres anvendelse som medikamenter.
IL99434A0 (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and pharmaceutical compositions containing them
DK259388A (da) 1-(n-(2-alkylthio-10h-phenothiazin-10-yl)alkyl)-4-benzoylpiperidiner, deres fremstilling og anvendelse